Although we decided that this was the most appropriate solution in order to investigate those interactions on a patient-based (instead of a tumor focus-based level), this might introduce some bias in terms of tumor volume and interpretation of MGMT promotor methylation and Ki-67 proliferation indices, respectively (since those molecular data might come from sampling of another tumor lesion). Here, MKI67 is linked to neoplasm.